IDH2 and astrocytoma (excluding glioblastoma): However, IDH-mutant WHO grade II and III astrocytomas were associated with a better OS than their IDH wild-type counterparts, and, strikingly, IDH wild-type WHO grade II and III had a worse survival than IDH-mutant GBM.